$PRAX Cashflow Statement | Understand Stock

$PRAX

$267.59 +$0.20 (0.07%) Close

$PRAX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Stock-based compensation expense
Non-cash operating lease expense
Amortization of premiums and discounts on marketable securities, net
Non-cash collaboration and license agreement expense
Other non-cash adjustments
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Operating lease liabilities
Deferred revenue
Other
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of marketable securities
Maturities of marketable securities
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from at-the-market offerings, net of issuance costs
Proceeds from initial public offering of common stock, net of issuance costs
Payment of issuance costs for initial public offering
Payment of issuance costs for at-the-market offerings
Payments of tax withholdings related to vesting of restricted stock units
Proceeds from exercise of options and employee stock purchase plan contributions
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
Repurchase of Series C redeemable convertible preferred stock
Proceeds from exercise of options and employee stock purchase plan purchases
Net cash provided by financing activities

Increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Operating lease right-of-use assets obtained in exchange for operating lease liabilities
Offering costs included in accrued expenses
Purchases of property and equipment included in accrued expenses
Accretion of redeemable convertible preferred stock to redemption value
Offering costs from follow-on public offering included in accounts payable
Follow-On Offering
At-The-Market Offering
Supplemental disclosures of non-cash activities:
Offering costs from in accounts payable / accrued expenses
Follow-On Offering
At-The-Market Offering
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments